Contract 36E79719A0025
Astellas Pharma Us, Inc. · Department Of Veterans Affairs · September 27, 2021
Astellas Pharma Us, Inc. was awarded a federal contract by Department Of Veterans Affairs on September 27, 2021 for an undisclosed amount of work in pharmaceutical preparation manufacturing. This is a task or delivery order issued under parent IDIQ V797D30296. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 27, 2021. If all options are exercised, the contract could reach $1.09 million.
Contract details
- PIID
- 36E79719A0025
- Parent IDIQ
- V797D30296
- Award type
- —
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- September 27, 2021
- Latest action
- September 27, 2021
Description
BPA CANCELLATION.
Modification timeline
-
September 27, 2021Mod P00012 · Legal Contract Cancellation$0
-
September 27, 2021Mod P00011 · Other Administrative ActionPRICE CHANGE FOR THREE XTANDI NDCS.$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36E79719A0025?
Contract 36E79719A0025 is a federal contract awarded to Astellas Pharma Us, Inc. by Department Of Veterans Affairs on September 27, 2021 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 36E79719A0025?
Astellas Pharma Us, Inc. won contract 36E79719A0025 from Department Of Veterans Affairs.
How much is contract 36E79719A0025 worth?
Contract 36E79719A0025 has obligated $0 to date but carries a potential ceiling of $1.09 million if fully funded and all options are exercised.